Novelty of biotechnological inventions and further therapeutic use in Europe

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

This article analyses recent European case law and changes following the entry into force of the European Patent Convention (EPC) 2000 in relation to the assessment of the novelty of certain biotechnological inventions, including claims to products and method/use claims.


Unlock unlimited access to all IAM content